Filter
3248
Filtered Results: 3248
Text search:
WHO
drug
use
indicators
Featured
Recommendations
272
New Publications
1014
Language
Document type
No document type
2125
Studies & Reports
484
Guidelines
322
Manuals
121
Strategic & Response Plan
121
Training Material
26
Fact sheets
22
Situation Updates
17
Infographics
8
Brochures
1
Online Courses
1
Countries / Regions
India
199
Kenya
117
Global
100
Ethiopia
94
Uganda
90
Nepal
81
Nigeria
75
Malawi
75
Tanzania
75
Western and Central Europe
69
South Africa
65
Zambia
64
Sierra Leone
62
Liberia
62
Ghana
57
Bangladesh
54
Myanmar / Burma
52
Latin America and the Carribbean
51
Rwanda
45
Africa
44
Namibia
41
Ukraine
33
Eastern Europe
33
Zimbabwe
32
Philippines
31
Cambodia
30
Lesotho
29
South–East Asia Region
28
Asia
25
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
16
Burkina Faso
15
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
East and Southern Africa
11
Russia
11
Syria
10
Haiti
10
Eastern Europe and Central Asia
10
Pakistan
10
Colombia
9
Albania
9
West and Central Africa
9
Georgia
9
Venezuela
8
Middle East and North Africa
8
Brazil
8
Thailand
6
Moldova
6
South Sudan
6
Laos
5
Peru
5
Guinea
5
USA
5
Germany
5
Lebanon
5
Sudan
5
North Macedonia
4
Tajikistan
4
Benin
4
China
4
Armenia
4
Western Pacific Region
4
Argentina
4
Vietnam
4
Timor Leste/ East Timor
3
Mexico
3
El Salvador
3
Chile
3
Afghanistan
3
Jordan
3
Bolivia
3
Papua New Guinea
3
Sri Lanka
3
Bhutan
3
Iraq
3
Turkey
2
Kazakhstan
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Mongolia
2
Saudi Arabia
2
Paraguay
2
North America
2
Turkmenistan
2
France
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Central African Republic
2
Honduras
2
Mali
2
North Korea
1
Serbia
1
Gambia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Italy
1
Hungary
1
Ireland
1
Gabon
1
Uruguay
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Nicaragua
1
Greece
1
Palestine
1
Poland
1
Libya
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1494
Clinical Guidelines
254
Public Health
178
Women & Child Health
109
Key Resources
78
Pharmacy & Technologies
40
Capacity Building
35
Toolboxes
HIV
384
TB
301
Mental Health
226
AMR
182
NTDs
91
COVID-19
83
Pharmacy
77
Caregiver
64
NCDs
62
Rapid Response
57
Planetary Health
40
Disability
32
Conflict
31
Global Health Education
31
Refugee
27
Ebola
25
Health Financing Toolbox
14
Polio
14
Natural Hazards
12
Cholera
10
Specific Hazards
9
Zika
6
Social Ethics
4
The recommendations in this guideline are intended to inform the development of relevant national- and local-level health policies and clinical protocols. Therefore, the target audience includes national and local public health policy-makers, implementers and managers of maternal and child health pr...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
